Results 11 to 20 of about 2,458,624 (375)
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems [PDF]
Addiction Science & Clinical Practice, 2021 Purpose Little is known about prevalence and treatment of OUD among youth engaged in primary care (PC). Medications are the recommended treatment of opioid use disorder (OUD) for adolescents and young adults (youth).
Sarah M. Bagley +16 more
doaj +2 more sources
Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York [PDF]
Substance Abuse Treatment, Prevention, and Policy, 2019 Background Medication for addiction treatment (MAT) has received much attention in recent years for treating individuals with opioid use disorders (OUD). However, these medications have been significantly underused among particular subgroups.
Charles J. Neighbors +5 more
doaj +2 more sources
Drug and Alcohol Dependence Reports, 2022 Introduction: Psychosocial support is recommended in conjunction with medication for opioid use disorder (MOUD), although optimal “dose,” modality, and timing of participation is not established.
Kathryn Hefner +13 more
doaj +2 more sources
Medications for opioid use disorders: clinical and pharmacological considerations [PDF]
Journal of Clinical Investigation, 2019 Carlos Blanco, Nora D. Volkow
openaire +4 more sources
Medication-Assisted Treatment for Opioid-Use Disorder [PDF]
Mayo Clinic Proceedings, 2019 The United States is in the midst of a national opioid epidemic. Physicians are encouraged both to prevent and treat opioid-use disorders (OUDs). Although there are 3 Food and Drug Administration-approved medications to treat OUD (methadone, buprenorphine, and naltrexone) and there is ample evidence of their efficacy, they are not used as often as they
Tyler S. Oesterle +3 more
openaire +6 more sources
Addiction Science & Clinical Practice, 2022 Background Medication for opioid use disorder (MOUD) reduces mortality, but few patients access MOUD. At a Federally Qualified Health Center (FQHC), we implemented a low barrier model of MOUD, including same-day MOUD initiation and a harm reduction ...
Jamie Carter +9 more
doaj +1 more source
Patterns of Routes of Administration and Drug Tampering for Nonmedical Opioid Consumption: Data Mining and Content Analysis of Reddit Discussions [PDF]
J Med Internet Res 2021;23(1):e21212, 2021 The complex unfolding of the US opioid epidemic in the last 20 years has been the subject of a large body of medical and pharmacological research, and it has sparked a multidisciplinary discussion on how to implement interventions and policies to effectively control its impact on public health.
arxiv +1 more source
Educating the community about the opioid epidemic and medications for opioid use disorder
The American Journal on Addictions, 2022 AbstractBackground and ObjectivesDespite overwhelming evidence of benefit, medications for opioid use disorder (MOUD) remain stigmatizing and more efforts are needed to educate health care professionals and the general public.MethodsWe developed and evaluated an educational program for graduate students studying health sciences, teaching them to ...
Jill M. Williams +5 more
openaire +2 more sources
Advancing emergency department–initiated buprenorphine
Journal of the American College of Emergency Physicians Open, 2021 Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid‐related overdoses during the COVID‐19 public health emergency.
Kristen Huntley +5 more
doaj +1 more source
JAMA Network Open, 2023 This cross-sectional study uses data from the 2021 National Survey on Drug Use and Health to estimate the receipt of medication for opioid use disorder among US adults with past-year opioid use disorder.
Jones, Christopher M. +4 more
openaire +2 more sources